StonvexLoading…
StonvexStonvexStonvexCore line items from INTU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $18.83B | $16.29B | $14.37B | $12.73B |
Operating Income | $4.92B | $3.63B | $3.14B | $2.57B |
Net Income | $3.87B | $2.96B | $2.38B | $2.07B |
EPS (Diluted) | $13.67 | $10.43 | $8.42 | $7.28 |
Total Assets | $36.96B | $32.13B | $27.78B | $27.73B |
Total Liabilities | $17.25B | $13.70B | $10.51B | $11.29B |
Cash & Equivalents | $2.88B | $3.61B | $2.85B | $2.80B |
Free Cash Flow OCF − CapEx | $6.12B | $4.69B | $4.84B | $3.73B |
Shares Outstanding | 279.13M | 280.27M | 280.42M | 281.93M |